Research news
Cancer Center Cessation Initiative launches new effort to help cancer patients quit smoking
12/10/2021
It’s well documented that smoking can lead to cancer. But in recent years, evidence has been mounting that continuing to smoke during cancer treatment can be just as harmful, or even worse.
Lung cancer screening guidelines may perpetuate disparities in health care
11/29/2021
Recent changes to national guidelines made more former and current smokers eligible for lung cancer screening, but a new study by a University of Wisconsin School of Medicine and Public Health radiologist shows they did little to close the gap bet...
Access to Medicare increases lung cancer screening rates
11/29/2021
If lung cancer is caught early enough, it’s treatable with a high chance of long survival. But many people at high risk because of their smoking history aren’t screened until they turn 65 and are eligible for Medicare coverage.
Patient with rare cancer uses telehealth to access clinical trial
05/20/2021
Today is National Clinical Trials Day, and UW Health wants to celebrate the researchers, nurses, physicians and experts in the lab who make clinical trials available and impactful for our patients and community. UW Health officials also say virtua...
Nataliya Uboha named faculty leader of Cancer Therapy Discovery and Development (CTD2) at UW Carbone Cancer Center
03/29/2021
Nataliya Uboha, MD, PhD, has been selected to lead the Cancer Therapy Discovery and Development (CTD2) program at the University of Wisconsin Carbone Cancer Center.
Study finds analyzing DNA in urine could help detect cancer
02/18/2021
A study published this week in Science Translational Medicine describes how urinalysis could potentially be used to detect some forms of cancer.
Jamey Weichert, Zachary Morris leading a team to develop new way to help immune system fight back against cancer
01/07/2021
Scientists at the University of Wisconsin School of Medicine and Public Health are breaking new ground to make cancer cells more susceptible to attack by the body’s own immune system.
First-in-humans clinical trial to treat children with relapsed neuroblastoma opens at American Family Children’s Hospital
11/19/2020
A first-in-humans clinical trial for children with relapsed or refractory neuroblastoma has opened at American Family Children's Hospital (AFCH) and is being conducted by researchers at University of Wisconsin School of Medicine and Public Hea...
UW Carbone Cancer Center receives FDA clearance to test new regenerative medicine therapy for radiotherapy-induced dry mouth
09/08/2020
The University of Wisconsin Carbone Cancer Center has the go-ahead to start clinical trials on a first-in-human cell therapy to treat a common side effect of radiation therapy.
Remembering Heidi Dvinge: scientist, colleague, mentor and friend
04/23/2020
Heidi Dvinge, PhD, assistant professor of Biomolecular Chemistry and a member of the Carbone Cancer Center, passed away on September 20, 2019. With great sorrow over the loss of a brilliant young scientist, colleague, mentor and friend, we honor h...
Stem cells could help cancer patients fight dangerous infections
01/30/2020
Scientists at the University of Wisconsin–Madison have developed a more efficient way to grow the white blood cells, which serve as front-line defenders against bacterial infections but are often depleted as a potentially deadly side effect o...
Study: Access to Medicare increases cancer detection
01/13/2020
Access to Medicare significantly impacts detection of certain cancers and life expectancy following cancer diagnosis, according to a new study from the UW School of Medicine and Public Health that was recently published online in the Journal of Po...
UW Carbone Cancer Center physicians: All cancer patients should be screened for Hepatitis C
12/31/2019
All cancer patients should be screened for exposure to the Hepatitis C virus because cancer treatment can make an active viral infection worse, according to a statement published this month in the Journal of Oncology Practice.
Biostatistics and Medical Informatics Department tapped for $11.8 million national coordinating center
10/02/2019
A University of Wisconsin-Madison professor and his team have been chosen to lead the nation’s coordinating center for the National Cancer Institute (NCI) Cancer Prevention Clinical Trials Network (CP-CTNet).
UW-Madison cancer research conference focuses on targeted radionuclide therapy
09/19/2019
University of Wisconsin-Madison is hosting a national conference on targeted radionuclide therapy (TRT), a promising new technology that combines cytotoxic radioisotopes with molecularly targeted agents to produce an anti-cancer therapy capable of...
Simultaneous infection by two viruses the key to studying rare lymphoma
07/29/2019
New research has found that a rare blood cancer can be simulated in the lab only by simultaneously infecting white blood cells with two viruses typically found in the tumors.
Researchers probe cell division defects to gain insight into cancer
07/08/2019
From bugs to plants to animals, for all living things to grow they must create more cells.
Study: risk-based breast cancer screenings lack predictive value
06/17/2019
Starting breast-cancer screenings based on personal risk factors instead of age in women 40-49 years of age may significantly delay the detection of some early-stage breast cancers while also decreasing the number of false-positive mammograms and ...
UW study provides potential treatment strategy for aggressive lymphoma
06/12/2019
A research team at the University of Wisconsin Carbone Cancer Center has found a new tumor-causing mechanism that contributes to the development of the most common form of non-Hodgkin lymphoma.
Darcie Moore, Zachary Morris receive 2019 Shaw Scientist Awards
06/04/2019
University of Wisconsin School of Medicine and Public Health assistant professor of neuroscience Darcie Moore, PhD, and assistant professor of human oncology Zachary Morris, MD, PhD, are recipients of 2019 Shaw Scientist Awards from the Greater Mi...
Carbone Cancer Center members take new leadership roles
04/09/2019
Four members of the University of Wisconsin Carbone Cancer Center have been named to new leadership roles.
Personalized in vitro model enables drug screening for kidney cancer
03/25/2019
One way to treat the most common type of kidney cancer is to use anti-angiogenic drugs to cut off the blood supply to the tumors, but patients respond differently to the drugs, and choosing the wrong one can make the cancer grow faster.
The Ride funds $365,000 in research at Carbone Cancer Center
02/11/2019
On a beautiful September Sunday, hundreds of bicyclists pedaled the roads of eastern Dane County on The Ride to raise money for cancer research.
First Carbone Cancer Center patient receives experimental therapy to prevent infections during chemotherapy
12/20/2018
Michael Toelle, superintendent of the Tomorrow River Schools, recently became the first patient at the University of Wisconsin Carbone Cancer Center to be infused with an experimental cellular therapy designed to prevent infections in leukemia pat...
Wisconsin researchers well-represented at international radiation oncology conference
12/12/2018
The 60th annual meeting of the American Society for Radiation Oncology (ASTRO), the world’s premier radiation oncology society, got underway this week in San Antonio, Texas, with a strong Wisconsin presence.
UW Carbone blood researchers to present at hematology conference
11/30/2018
When dozens of University of Wisconsin blood researchers escape to sunny San Diego this weekend, they will not just be there for the weather – they are attending the American Society for Hematology’s (ASH) Annual Conference.
Breast cancer expert Kari Wisinski joins Big Ten research leadership
11/20/2018
Kari Wisinski, MD, a breast cancer specialist with the University of Wisconsin Carbone Cancer Center, has been named to the steering committee of the Big Ten Cancer Research Consortium.
Mutations in key blood cell protein disrupt development, predispose to leukemia
11/12/2018
When a key gene in blood cell development, GATA-2, is mutated, it causes a predisposition to the development of acute myeloid leukemia (AML), and the changes in GATA-2 were believed to diminish its protein function.
Sean Ronnekleiv-Kelly earns 2018 Carbone Young Investigator Award
11/05/2018
Sean Ronnekleiv-Kelly, MD, a surgical oncologist with the UW Carbone Cancer Center and Department of Surgery, has been awarded the 2018 Paul P. Carbone Young Investigator Award to study causes of and treatments for pancreatic cancer. He joine...
Upcoming event focuses on men's health
10/31/2018
Getting men to talk about their health at all takes some doing, so Second Baptist Church is hosting a Madison event targeted at men’s health awareness. As a collaborative effort with the Cancer Health Disparities Initiative of the UW Carbone...
Evie Carchman awarded grant to study anal cancer
07/25/2018
While people infected with HIV are living longer due to better therapies, their weakened immune systems are linked to what is now a leading cause of death in the HIV population: cancer.
Cai group recognized for research achievements at annual imaging meeting
07/10/2018
The Molecular Imaging and Nanotechnology Laboratory had another successful year at June's Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting in Philadelphia.
Forgotten molecules find new purpose at Carbone Cancer Center
07/10/2018
On a rainy day last fall, chemist Scott Wildman left his office on the UW–Madison campus and drove to a retirement community on the city’s west side to bring 40 years of scientific work out of the dark.
UW Carbone study to look for ways to personalize therapy in colorectal cancer
06/15/2018
A five-year, $3 million grant from the National Cancer Institute will support UW Carbone Cancer Center physician-researcher Dusty Deming, MD, and colleagues in their pursuit of more effective treatments for colorectal-cancer patients.
UW-Madison researchers discover effective way to generate powerful blood cells for immunotherapy
05/25/2018
Scientists at the University of Wisconsin School of Medicine and Public Health have found a potentially improved method for creating T cells to treat cancer and infections.
Study seeks 'extreme survivors' of metastatic breast cancer
05/08/2018
Some patients can live for years, and even decades, after breast cancer has spread to their bones and other tissues.
UW Carbone scientists to present at annual cancer research conference
04/16/2018
As cancer researchers from across the country descend on Chicago this week for the American Association of Cancer Research’s annual conference, University of Wisconsin Carbone Cancer Center faculty, staff and students are among them.
Fewer mammography recalls associated with higher rates of breast cancers found between screenings
04/03/2018
Calling fewer women back for more testing after a suspicious mammography finding is associated with higher rates of breast cancers found between screenings.
UW Carbone Cancer Center receives 'outstanding' grade on renewal
02/14/2018
Every five years, the UW Carbone Cancer Center receives a thorough check-up from the nation’s top cancer researchers. Leaders recently learned that it passed its review with flying colors and will retain its designation as Wisconsin’s ...
Dense breasts, inflammation linked to cancer risk
02/13/2018
A new study by University of Wiscconsin Carbone Cancer Center researchers has found that dense breasts and inflammation are associated with poor prognosis in breast-cancer patients, and suggests that an FDA-approved drug may improve prognosis for ...